Racquel Bracken is a General Partner at Venrock, where she focuses on pharmaceutical and biotech investments and company creation. She serves on the boards of MBrace Therapeutics (Board Chair), Topaz Therapeutics, Scithera, and Federation Bio, and has invested in companies including Cyteir Therapeutics, MBrace Therapeutics, Federation Bio, Topaz Therapeutics, and Scithera. Before Venrock, she was Acting Chief Executive Officer at Confluence Therapeutics; Head of Business Development and Marketing Director at Clovis Oncology; an Associate on the investment team at Domain Associates; led Business Development at Calixa Therapeutics; and a Consultant at Easton Associates (now Navigant Consulting). Racquel graduated from Harvard University and lives in Palo Alto, California.
Racquel Bracken, General Partner @ Venrock. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Racquel Bracken from . Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Racquel
Map your path to Racquel instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Racquel
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.